Resverlogix Corp. J (TSE:RVX)

TSX:RVX

RVX

Resverlogix

RESEARCH TOOLSreports

Resverlogix (RVX) Price & Analysis

34 Followers

RVX Stock Chart & Stats

C$0.10

C$0.00(0.00%)

At close: Jan 08 4:00 PM EST

C$0.10

C$0.00(0.00%)

Day’s Range― - ―

52-Week RangeC$0.04 - C$0.30

Previous CloseN/A

Volume1.00K

Average Volume (3M)37.18K

Market Cap

C$33.17M

Enterprise ValueC$41.20M

Total Cash (Recent Filing)C$89.05K

Total Debt (Recent Filing)C$19.51M

Price to Earnings (P/E)―

Beta0.72

Next Earnings

May 19, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding315,917,270

10 Day Avg. Volume62,041

30 Day Avg. Volume37,183

Financial Highlights & Ratios

PEG Ratio0.00

Price to Book (P/B)-0.13

Price to Sales (P/S)0.00

P/FCF Ratio-2.43

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Resverlogix News

Resverlogix Hit With Management Cease Trade Order Over Late Annual Filings

An announcement from Resverlogix ( ($TSE:RVX) ) is now available. Resverlogix Corp. has received a management cease trade...

7d ago

Resverlogix Faces Filing Delay as Alberta Regulator Reviews Cease Trade Request

The latest update is out from Resverlogix ( ($TSE:RVX) ). Resverlogix Corp. has confirmed it will miss the...

8d ago

Resverlogix Faces Audit Delay and Seeks Management Cease Trade Order

An update from Resverlogix ( ($TSE:RVX) ) is now available. Resverlogix Corp. has announced it will miss the...

22d ago

Resverlogix Converts $2.8 Million Interest into Equity in Insider-led Financing

Resverlogix ( ($TSE:RVX) ) has shared an update. Resverlogix Corp. has completed a CAD$2.8 million shares-for-interest private placement...

2M ago

Resverlogix Strengthens Board with Appointment of Legal Expert Bradley Glass

Resverlogix ( ($TSE:RVX) ) has provided an update. Resverlogix Corp. has appointed Bradley Glass, J.D., to its board...

5M ago

Resverlogix Corp. Advances Long-COVID Treatment Study with Apabetalone

Resverlogix Corp. (($TSE:RVX)) announced an update on their ongoing clinical study. Resverlogix Corp. is conducting a Phase II...

5M ago

RVX

Resverlogix Announces Shareholder Meeting Results and Strategic Focus

Resverlogix ( ($TSE:RVX) ) has issued an announcement. Resverlogix Corp. held its Annual Meeting of Shareholders in Calgary,...

9M ago

Resverlogix Showcases Apabetalone’s Heart Health Benefits

Resverlogix (TSE:RVX) has released an update. At the European Society of Cardiology Congress 2024, Resverlogix Corp. highlighted the...

2y ago

Resverlogix Secures Shareholder Approval and Debenture Extension

Resverlogix (TSE:RVX) has released an update. Resverlogix Corp. successfully conducted its Annual & Special Meeting, electing four directors...

2y ago

Resverlogix Amends Debenture Terms Amidst Therapy Development

Resverlogix (TSE:RVX) has released an update. Resverlogix Corp. has extended its secured convertible debenture with Shenzhen Hepalink Pharmaceutical...

2y ago

RVX FAQ

What was Resverlogix Corp. J’s price range in the past 12 months?

Resverlogix Corp. J lowest stock price was C$0.04 and its highest was C$0.30 in the past 12 months.

What is Resverlogix Corp. J’s market cap?

Resverlogix Corp. J’s market cap is C$33.17M.

When is Resverlogix Corp. J’s upcoming earnings report date?

Resverlogix Corp. J’s upcoming earnings report date is May 19, 2026 which is in 40 days.

How were Resverlogix Corp. J’s earnings last quarter?

Currently, no data Available

Is Resverlogix Corp. J overvalued?

According to Wall Street analysts Resverlogix Corp. J’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Resverlogix Corp. J pay dividends?

Resverlogix Corp. J does not currently pay dividends.

What is Resverlogix Corp. J’s EPS estimate?

Resverlogix Corp. J’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Resverlogix Corp. J have?

Resverlogix Corp. J has 315,917,270 shares outstanding.

What happened to Resverlogix Corp. J’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Resverlogix Corp. J?

Currently, no hedge funds are holding shares in TSE:RVX

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Resverlogix Corp. J

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. It is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases. Resverlogix Corp. has a partnership with Eversana Life Science Services, LLC to support the pending launch of the commercialization of apabetalone for Covid-19 in the United States and Canada. The company is headquartered in Calgary, Canada.